EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy

Shuang-Yin Lei iD, Hanjiao Qin, Shui Liu iD, Jiyao Sheng iD

International Journal of Nanomedicine · 2025-11 · Volume 20 · 13255-13292

DOI: 10.2147/ijn.s551752 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025-11. Verfasst von Shuang-Yin Lei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Second Hospital of Jilin University, Changchun, 130041, People's Republic of China. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (CDDP) and other platinum-based agents remain cornerstones of cancer therapy. However, drug resistance severely impairs their clinical efficacy and therapeutic potential. Extensive research has identified diverse CDDP resistance mechanisms, broadly categorized as pre-target, on-target, off-target, and post-target resistance. These mechanisms exhibit substantial heterogeneity across patients and tumor types, highlighting the complexity of resistance development. Notably, resistance to other platinum drugs shares similarities with CDDP, presenting a common therapeutic challenge. Leveraging insights into CDDP resistance, personalized therapeutic strategies offer promise to enhance anti-tumor efficacy and overcome platinum resistance. The integration of nanotechnology and precision medicine has emerged as a pivotal frontier in oncology, where nanotechnology-based drug delivery systems (NDDSs) serve as multifunctional vectors for co-delivering CDDP and resistance-modulating agents. These intelligent platforms enable precise targeting and active circumvention of resistance mechanisms. This review comprehensively explores innovative NDDS strategies to overcome CDDP resistance, focusing on pre-target, on-target, off-target, and post-target mechanisms within a precision medicine framework. By synthesizing these advancements, we aim to provide a forward-looking perspective on NDDSs development and their potential to address the persistent challenge of platinum resistance in anti-cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmAntineoplastic AgentsNeoplasmsNanoparticle Drug Delivery SystemHumansDrug Delivery SystemsPrecision MedicineNanomedicineAnimalsNanotechnology

Stichwörter der Autor:innen

cancercisplatindrug resistancenanotechnologyplatinum-based drugs

Substanzen

CisplatinAntineoplastic AgentsNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Second Hospital of Jilin University, Changchun, 130041, People's Republic of China.
  • The First Norman Bethune Clinical College of Jilin University, Changchun, 130021, People's Republic of China.
  • Department of Radiotherapy, Second Hospital of Jilin University, Changchun, 130041, People's Republic of China.
  • State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, 130012, People's Republic of China.

ORCID-Profile: Shuang-Yin Lei, Shui Liu, Jiyao Sheng

Zitieren

APA

Lei, S. Y., Qin, H., Liu, S., & Sheng, J. (2025). Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. International Journal of Nanomedicine, Volume 20, 13255-13292. https://doi.org/10.2147/ijn.s551752

Vancouver

Lei SY, Qin H, Liu S, Sheng J. Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. International Journal of Nanomedicine. 2025;Volume 20:13255-13292. doi:10.2147/ijn.s551752

BibTeX
@article{Lei2025,
  author = {Lei, Shuang-Yin and Qin, Hanjiao and Liu, Shui and Sheng, Jiyao},
  title = {Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  volume = {Volume 20},
  pages = {13255--13292},
  doi = {10.2147/ijn.s551752}
}
Kostenlos starten →